Seeking Alpha

Sequenom (SQNM) says it's completed its private offering of $130M aggregate principal amount of...

Sequenom (SQNM) says it's completed its private offering of $130M aggregate principal amount of 5% convertible senior notes due 2017. The company plans to use the proceeds to fund the commercialization of the MaterniT21 PLUS laboratory-developed test, as well as for other general corporate purposes.
Comments (1)
  • Sorgy
    , contributor
    Comment (1) | Send Message
     
    Pretty amazing that the price has not moved considering they may do 100,000 test this year and are gearing up to do 400,000 going forward. Long hangover from the data mistake of 5 years ago.
    18 Sep 2012, 12:59 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs